Chinese CKD-MBD Prevalence Survey (CRISS-MBD)
Chinese Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Prevalence Survey
1 other identifier
observational
10,254
1 country
40
Brief Summary
This is a multi-center cross sectional epidemiological study. The purpose of this study is to investigate the prevalence of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) in Chinese population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2020
Longer than P75 for all trials
40 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 29, 2020
CompletedFirst Submitted
Initial submission to the registry
January 14, 2021
CompletedFirst Posted
Study publicly available on registry
January 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedApril 10, 2024
April 1, 2024
4.1 years
January 14, 2021
April 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The prevalence of hyperphosphatemia
The prevalence of hyperphosphatemia (serum phosphate \> 1.45mmol/L) in the whole study population and in participants with different CKD stages.
At the end of the enrollment.
Secondary Outcomes (5)
The prevalence of hypocalcemia
At the end of the enrollment.
The prevalence of secondary hyperparathyroidism
At the end of the enrollment.
The prevalence of hypercalcemia
At the end of the enrollment.
The prevalence of bone fracture
At the end of the enrollment.
The prevalence of vascular calcification
At the end of the enrollment.
Eligibility Criteria
This study plans to include hospitalized CKD patients who are not on dialysis and dialysis patients followed regularly in HD centers or PD centers.
You may qualify if:
- Kidney damage for ≥ 3 months, and one of the following criteria:
- Glomerular filtration rate (GFR) \<60 mL/min/1.73m2 for 3 months or more, irrespective of cause.
- proteinuria (\>30 mg of urinary albumin excretion per gram of urinary creatinine, \> 50 mg of urinary protein excretion per gram of urinary creatinine, \>1+ for proteinuria in dipstick, \> 0.3g of 24 hour urine protein)
- structural renal abnormalities
- hospitalized patients not on dialysis or dialysis patients followed regularly in Hemodialysis centers or Peritoneal Dialysis centers
You may not qualify if:
- no available test results within 3 months prior to this study
- no available information of medication or past medical history
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Limeng Chenlead
Study Sites (40)
Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, 100070, China
Beijing Tongren Hospital, Capital Medical University
Beijing, Beijing Municipality, 100730, China
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100730, China
Beijing Lu-He Hospital, Capital Medical University
Beijing, Beijing Municipality, 101149, China
The First Hospital of Fangshan District, Beijing
Beijing, Beijing Municipality, 102400, China
Beijing Daxing District People's Hospital
Beijing, Beijing Municipality, 102600, China
The First Affiliated Hospital, Chongqing Medical University
Chongqing, Chongqing Municipality, 400016, China
Chongqing Hospital of Traditional Chinese Medicine
Chongqing, Chongqing Municipality, 400021, China
The Ninth People's Hospital of Chongqing
Chongqing, Chongqing Municipality, 400700, China
The Third Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 401120, China
People's Hospital of Liangping District, Chongqing
Chongqing, Chongqing Municipality, 405200, China
The People's Hospital of Fengdu County
Chongqing, Chongqing Municipality, 408200, China
The People's Hospital of Nanchuan District, Chongqing
Chongqing, Chongqing Municipality, 408400, China
Fujian Provincial Hospital
Fuzhou, Fujian, 350001, China
Zhongshan Hospital Affiliated to Xiamen University
Xiamen, Fujian, 361000, China
Zhangzhou People's Hospital
Zhangzhou, Fujian, 363099, China
Shunde Hospital of Southern Medical University, The first People's Hospital of Shunde
Foshan, Guangdong, 528300, China
Panyu Central Hospital
Guangzhou, Guangdong, 511400, China
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Guangzhou, Guangdong, 520120, China
The Seventh Affiliated Hospital, Sun Yat-sen University
Shenzhen, Guangdong, 518000, China
The People's Hospital of Longhua, The Affiliated Hospital of Southern Medical University
Shenzhen, Guangdong, 518109, China
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, 530021, China
Xiangya Hospital of Central South University
Changsha, Hunan, 410008, China
Third People's Hospital of Yiyang
Yiyang, Hunan, 413000, China
Anshan Central Hospital, Lishan District
Anshan, Liaoning, 114000, China
Benxi Steel General Hospital of Liaoning Health Industry Group
Benxi, Liaoning, 117000, China
Dalian University Affiliated Xinhua Hospital
Dalian, Liaoning, 116001, China
The First Hospital of China Medical University
Shenyang, Liaoning, 110001, China
Traditional Chinese Hospital of Guyuan
Guyuan, Ningxia, 756000, China
People's Hospital of Longde County
Guyuan, Ningxia, 756300, China
The Fifth People's Hospital of Ningxia Hui Autonomous Region
Shizuishan, Ningxia, 753000, China
People's Hospital of Wuzhong
Wuzhong, Ningxia, 751100, China
People's Hospital of Tongxin County
Wuzhong, Ningxia, 751300, China
People's Hospital of Yanchi County
Wuzhong, Ningxia, 751500, China
People's Hospital of Yuanzhou District
Wuzhong, Ningxia, 756000, China
Ningxia Chinese Medicine Research Center
Yinchuan, Ningxia, 750001, China
People's Hospital of Ningxia Hui Autonomous Region
Yinchuan, Ningxia, 750001, China
The First People's Hospital of Yinchuan
Yinchuan, Ningxia, 750001, China
People's Hospital of Xinjiang Uygur Autonomous Region
Ürümqi, Xinjiang, 830001, China
The Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310000, China
Related Publications (2)
Zhou C, Wang F, Wang JW, Zhang LX, Zhao MH. Mineral and Bone Disorder and Its Association with Cardiovascular Parameters in Chinese Patients with Chronic Kidney Disease. Chin Med J (Engl). 2016 Oct 5;129(19):2275-80. doi: 10.4103/0366-6999.190678.
PMID: 27647184RESULTKong X, Zhang L, Zhang L, Chen N, Gu Y, Yu X, Liu W, Chen J, Peng L, Yuan W, Wu H, Chen W, Fan M, He L, Ding F, Chen X, Xiong Z, Zhang J, Jia Q, Shi W, Xing C, Tang X, Hou F, Shu G, Mei C, Wang L, Xu D, Ni Z, Zuo L, Wang M, Wang H. Mineral and bone disorder in Chinese dialysis patients: a multicenter study. BMC Nephrol. 2012 Sep 21;13:116. doi: 10.1186/1471-2369-13-116.
PMID: 22994525RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Limeng Chen, MD, PhD
Peking Union Medical College Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Deputy Director, Department of Nephrology
Study Record Dates
First Submitted
January 14, 2021
First Posted
January 20, 2021
Study Start
November 29, 2020
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
April 10, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share
To comply with laws in China, local regulations and hospital policy, IPD sharing might be restricted.